EWSR1 is an inclusion criterion in 8 clinical trials for Ewing sarcoma, of which 7 are open and 1 is closed. Of the trials that contain EWSR1 status and Ewing sarcoma as inclusion criteria, 5 are phase 1 (4 open), 2 are phase 1/phase 2 (2 open), and 1 is phase 2 (1 open) [4].

EWSR1 is an inclusion criterion in 4 clinical trials for malignant solid tumor, of which 4 are open and 0 are closed. Of the trials that contain EWSR1 status and malignant solid tumor as inclusion criteria, 1 is phase 1 (1 open) and 3 are phase 1/phase 2 (3 open) [4].

EWSR1 is an inclusion criterion in 2 clinical trials for clear cell sarcoma of soft tissue, of which 2 are open and 0 are closed. Of the trials that contain EWSR1 status and clear cell sarcoma of soft tissue as inclusion criteria, 2 are phase 2 (2 open) [4].

EWSR1 is an inclusion criterion in 1 clinical trial for chondrosarcoma, of which 1 is open and 0 are closed. Of the trial that contains EWSR1 status and chondrosarcoma as inclusion criteria, 1 is phase 2 (1 open) [4].

EWSR1 is an inclusion criterion in 1 clinical trial for dedifferentiated chondrosarcoma, of which 1 is open and 0 are closed. Of the trial that contains EWSR1 status and dedifferentiated chondrosarcoma as inclusion criteria, 1 is phase 2 (1 open) [4].

EWSR1 is an inclusion criterion in 1 clinical trial for desmoplastic small round cell tumor, of which 1 is open and 0 are closed. Of the trial that contains EWSR1 status and desmoplastic small round cell tumor as inclusion criteria, 1 is phase 1/phase 2 (1 open) [4].

EWSR1 is an inclusion criterion in 1 clinical trial for Ewing sarcoma/peripheral primitive neuroectodermal tumor, of which 1 is open and 0 are closed. Of the trial that contains EWSR1 status and Ewing sarcoma/peripheral primitive neuroectodermal tumor as inclusion criteria, 1 is phase 2 (1 open) [4].

EWSR1 is an inclusion criterion in 1 clinical trial for myxoid liposarcoma, of which 1 is open and 0 are closed. Of the trial that contains EWSR1 status and myxoid liposarcoma as inclusion criteria, 1 is phase 1 (1 open) [4].

EWSR1 is an inclusion criterion in 1 clinical trial for non-hodgkin lymphoma, of which 1 is open and 0 are closed. Of the trial that contains EWSR1 status and non-hodgkin lymphoma as inclusion criteria, 1 is phase 1 (1 open) [4].

EWSR1 is an inclusion criterion in 1 clinical trial for osteosarcoma, of which 1 is open and 0 are closed. Of the trial that contains EWSR1 status and osteosarcoma as inclusion criteria, 1 is phase 1 (1 open) [4].

EWSR1 is an inclusion criterion in 1 clinical trial for primitive neuroectodermal tumor, of which 1 is open and 0 are closed. Of the trial that contains EWSR1 status and primitive neuroectodermal tumor as inclusion criteria, 1 is phase 1 (1 open) [4].

EWSR1 is an inclusion criterion in 1 clinical trial for sarcoma, of which 1 is open and 0 are closed. Of the trial that contains EWSR1 status and sarcoma as inclusion criteria, 1 is phase 1 (1 open) [4].

EWSR1 is an inclusion criterion in 1 clinical trial for soft tissue sarcoma, of which 1 is open and 0 are closed. Of the trial that contains EWSR1 status and soft tissue sarcoma as inclusion criteria, 1 is phase 1 (1 open) [4].